OXFORD, England, Nov. 18, 2025 /PRNewswire/ -- Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, today announced the successful completion of the research phase ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

In most developing tissues, signals called morphogens act like lighthouses, guiding nearby cells toward their fate and ...

This study provides valuable data on the role of Hsd17b7, a gene involved in cholesterol biosynthesis, as a potential regulator of mechanosensory hair cell function. The authors used both zebrafish ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by ...

Twist Bioscience Corporation (NASDAQ:TWST) is one of the best gene-editing stocks to buy according to hedge funds.

Penn and CHOP researchers will utilize the new protocol to distribute customizable drugs that target specific genetic disorders.

Scientists at Northwestern Medicine have developed a new genetic risk score that predicts who is most likely to experience irregular or dangerous heart rhythms. The test merges several types of ...

Scientists have sequenced the oldest RNA from a 40,000-year-old mammoth named Yuka, unlocking genetic activity from its final ...

ChristianaCare’s Gene Editing Institute says it has found a way to reverse chemotherapy resistance in one of the most common ...

Research will focus on the genome-wide identification of microexons to advance the knowledge on gene functions.

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...